NCT00492570View on ClinicalTrials.gov

GER-009-06-AVX Early Therapy in Multiple Sclerosis

CompletedOBSERVATIONAL
Enrollment

230

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

October 31, 2007

Study Completion Date

December 31, 2008

Conditions
Relapsing-Remitting Multiple Sclerosis
Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY

NCT00492570 - GER-009-06-AVX Early Therapy in Multiple Sclerosis | Biotech Hunter | Biotech Hunter